Synchron raises $75 M in Series C round led by ARCH Venture Partners

• ByStartupStory     |    December 16, 2022

The leading implantable brain computer interface company Synchron has raised $75M in Series C round led by ARCH Venture Partners. The funding has happened in the Series C financing round led by ARCH Venture Partners. The new investors like Gates Frontier, Reliance Digital Health Limited, Bezos Expeditions, Greenoaks, Alumni Ventures, Moore Strategic Ventures, Project X  and the existing investors including Khosla Ventures, METIS, Forepont Capital Partners, NeuroTechnology Investors, ID8 Investments, Shanda Group, and the University of Melbourne etc also participated in the same. 

The company is planning to use the fund for accelerating the development of its platform product and launch a pivotal clinical trial. Ari Nowacek from ARCH Venture Partners will join Synchron’s Board, and ARCH Co-founder and Managing Director Robert Nelsen will join as a Board Observer.

“We have an opportunity to deliver a first-in-class commercial BCI. The problem of paralysis is much larger than people realise. 100 million people worldwide have upper limb impairment,” said Tom Oxley, CEO & Founder, Synchron. “We are extremely excited to work with ARCH and this world-class syndicate to bring this technology to the people who need it.” he added.

Synchron was founded by University of Melbourne Associate Professors Thomas Oxley and Nicholas Opie in 2006. Syncron provides industry-leading aftermarket service software solutions that empower top manufacturers to increase profits & product uptime.

Follow Startup Story